|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/24/22 CollPlant Biotechnologies Ltd. 20-F 12/31/21 80:8.1M EdgarAgents LLC/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual Report HTML 1.54M
2: EX-8.1 Subsidiaries of the Company HTML 23K
5: EX-13.1 Annual or Quarterly Report to Security Holders HTML 23K
6: EX-13.2 Annual or Quarterly Report to Security Holders HTML 23K
3: EX-12.1 Statement re: the Computation of Ratios HTML 26K
4: EX-12.2 Statement re: the Computation of Ratios HTML 27K
7: EX-15.1 Consent of Kost Forer Gabbay & Kasierer, A Member HTML 22K
Firm of Ernst & Young Global, Independent
Registered Public Accounting Firm
8: EX-15.2 Consent of Kesselman & Kesselman, A Member Firm of HTML 23K
Pricewaterhousecoopers International Limited,
Independent Registered Public Accounting Firm.
14: R1 Document And Entity Information HTML 97K
15: R2 Consolidated Balance Sheets HTML 139K
16: R3 Consolidated Balance Sheets (Parentheticals) HTML 32K
17: R4 Consolidated Statements of Operation HTML 88K
18: R5 Consolidated Statements of Shareholders? Equity HTML 82K
19: R6 Consolidated Statements of Shareholders? Equity HTML 28K
(Parentheticals)
20: R7 Consolidated Statements of Cash Flows HTML 127K
21: R8 General HTML 28K
22: R9 Significant Accounting Policies HTML 90K
23: R10 Fair Value Measurements HTML 35K
24: R11 Property and Equipment HTML 32K
25: R12 Inventories HTML 28K
26: R13 Operating Leases HTML 43K
27: R14 Commitments HTML 29K
28: R15 Development , Exclusivity and Option Products HTML 38K
Agreements
29: R16 Share Capital HTML 121K
30: R17 Income Tax HTML 39K
31: R18 Supplementary Financial Statement Information HTML 54K
32: R19 Subsequent Events HTML 26K
33: R20 Accounting Policies, by Policy (Policies) HTML 313K
34: R21 Significant Accounting Policies (Tables) HTML 27K
35: R22 Fair Value Measurements (Tables) HTML 34K
36: R23 Property and Equipment (Tables) HTML 31K
37: R24 Inventories (Tables) HTML 28K
38: R25 Operating Leases (Tables) HTML 40K
39: R26 Share Capital (Tables) HTML 88K
40: R27 Income Tax (Tables) HTML 33K
41: R28 Supplementary Financial Statement Information HTML 58K
(Tables)
42: R29 Significant Accounting Policies (Details) HTML 38K
43: R30 Significant Accounting Policies (Details) - HTML 46K
Schedule of estimated useful lives property and
equipment
44: R31 Fair Value Measurements (Details) HTML 26K
45: R32 Fair Value Measurements (Details) - Schedule of HTML 34K
assumptions used for the models
46: R33 Fair Value Measurements (Details) - Schedule of HTML 30K
level 3 anti-dilution instrument
47: R34 Property and Equipment (Details) HTML 27K
48: R35 Property and Equipment (Details) - Schedule of HTML 46K
property and equipment
49: R36 Inventories (Details) HTML 25K
50: R37 Inventories (Details) - Schedule of inventories HTML 29K
51: R38 Operating Leases (Details) HTML 42K
52: R39 Operating Leases (Details) - Schedule of HTML 26K
supplemental cash flow information related to
leases
53: R40 Operating Leases (Details) - Schedule of HTML 40K
supplemental balance sheet information related to
leases
54: R41 Operating Leases (Details) - Schedule of HTML 41K
maturities of lease liabilities
55: R42 Commitments (Details) HTML 30K
56: R43 Development , Exclusivity and Option Products HTML 33K
Agreements (Details)
57: R44 Share Capital (Details) HTML 275K
58: R45 Share Capital (Details) - Schedule of shares HTML 45K
issued granted options
59: R46 Share Capital (Details) - Schedule of fair value HTML 42K
of options granted to employees on the date of
grant was computed using the Black-Scholes model
60: R47 Share Capital (Details) - Schedule of changes in HTML 54K
number of options granted
61: R48 Share Capital (Details) - Schedule of fair value HTML 36K
of options granted to non-employees
62: R49 Share Capital (Details) - Schedule of changes in HTML 49K
number of options granted
63: R50 Share Capital (Details) - Schedule of outstanding HTML 80K
and exercisable options
64: R51 Share Capital (Details) - Schedule of share-based HTML 32K
compensation
65: R52 Income Tax (Details) HTML 29K
66: R53 Income Tax (Details) - Schedule of deferred income HTML 34K
taxes
67: R54 Income Tax (Details) - Schedule of valuation HTML 28K
allowance
68: R55 Supplementary Financial Statement Information HTML 25K
(Details)
69: R56 Supplementary Financial Statement Information HTML 33K
(Details) - Schedule of balance sheet
70: R57 Supplementary Financial Statement Information HTML 38K
(Details) - Schedule of disaggregated revenues
text block
71: R58 Supplementary Financial Statement Information HTML 38K
(Details) - Schedule of revenues by geographical
area
72: R59 Supplementary Financial Statement Information HTML 38K
(Details) - Schedule of revenue by major customers
73: R60 Supplementary Financial Statement Information HTML 37K
(Details) - Schedule of changes in deferred
revenues relating to goods
74: R61 Supplementary Financial Statement Information HTML 39K
(Details) - Schedule of Financial income
(expenses) ,net
75: R62 Subsequent Events (Details) HTML 27K
78: XML IDEA XML File -- Filing Summary XML 147K
76: XML XBRL Instance -- f20f2021_collplantbio_htm XML 1.47M
77: EXCEL IDEA Workbook of Financial Reports XLSX 108K
9: EX-101.CAL XBRL Calculations -- clgn-20211231_cal XML 87K
10: EX-101.DEF XBRL Definitions -- clgn-20211231_def XML 718K
11: EX-101.LAB XBRL Labels -- clgn-20211231_lab XML 1.33M
12: EX-101.PRE XBRL Presentations -- clgn-20211231_pre XML 704K
13: EX-101.SCH XBRL Schema -- clgn-20211231 XSD 217K
79: JSON XBRL Instance as JSON Data -- MetaLinks 359± 479K
80: ZIP XBRL Zipped Folder -- 0001213900-22-014666-xbrl Zip 509K
Exhibit 8.1
Subsidiaries of CollPlant Biotechnologies Ltd.
CollPlant Biotechnologies Ltd. has the following subsidiaries.
| Subsidiary Name | Jurisdiction of Incorporation |
Percentage of Ownership | |||
| CollPlant Ltd. | Israel | 100 | % | ||
| CollPlant Inc. | Delaware | 100 | %1 |
(1) Indirectly, through our 100% ownership of CollPlant Ltd.
C:
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/04/24 CollPlant Biotechnologies Ltd. 20-F 12/31/23 74:6.9M EdgarAgents LLC/FA 3/29/23 CollPlant Biotechnologies Ltd. 20-F 12/31/22 73:6.8M EdgarAgents LLC/FA 12/30/22 CollPlant Biotechnologies Ltd. F-3 6:415K EdgarAgents LLC/FA 3/25/22 CollPlant Biotechnologies Ltd. S-8 3/25/22 4:81K EdgarAgents LLC/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/26/21 CollPlant Biotechnologies Ltd. 20-F 12/31/20 83:7.9M EdgarAgents LLC/FA 2/17/21 CollPlant Biotechnologies Ltd. 6-K 2/17/21 3:242K EdgarAgents LLC/FA 4/07/20 CollPlant Biotechnologies Ltd. 6-K 4/07/20 5:1.6M EdgarAgents LLC/FA 4/01/20 CollPlant Biotechnologies Ltd. 20-F 12/31/19 78:6.9M EdgarAgents LLC/FA 4/01/19 CollPlant Biotechnologies Ltd. 20-F 12/31/18 96:8.5M EdgarAgents LLC/FA 3/20/18 CollPlant Biotechnologies Ltd. 20-F 12/31/17 95:8M EdgarAgents LLC/FA 1/23/18 CollPlant Biotechnologies Ltd. F-1/A 7:3.8M Toppan Merrill-FA 11/22/17 CollPlant Biotechnologies Ltd. F-1/A 12:4.6M Toppan Merrill-FA 10/21/16 CollPlant Biotechnologies Ltd. F-1 12:5.5M Toppan Merrill-FA 2/20/15 Bank of New York/ADR Division F-6 3:303K CollPlant Biotechnologies Ltd. Emmet Marvin & Mart… LLP |